Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Virios Therapeutics, Inc. Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics, Inc. Announces Closing of Public Offering September 22, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics, Inc. Announces Pricing of Public Offering September 19, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics, Inc. Announces Proposed Public Offering September 19, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update August 11, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics, Inc. to Present at Investor Summit Group’s Q3 Virtual Conference August 10, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update on Thursday, August 11, 2022 August 04, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics’ Study Featured in Peer-Reviewed Journal Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders, Including in Patients with Comorbid Fibromyalgia June 01, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update May 12, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on Thursday, May 12, 2022 May 05, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update March 17, 2022 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination September 08, 2021 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics Announces New Social Media Profiles August 19, 2021 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics CEO Highlights Novel Therapeutic Approach for Treating Fibromyalgia and Irritable Bowel Syndrome in Stock News Now Video Interview August 16, 2021 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update August 12, 2021 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics Highlights Safety Data from Phase 2a Fibromyalgia Trial at the International Association for the Study of Pain (IASP) World Congress June 09, 2021 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics Announces Oral Presentation of Clinical Data at Digestive Disease Week® (DDW) May 24, 2021 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics to Present at the Benzinga Global Small Cap Conference May 07, 2021 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Virios Therapeutics to Present at the Needham Virtual Healthcare Conference April 07, 2021 From Virios Therapeutics, Inc. Via Business Wire Tickers VIRI Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.